Surgery Partners (Surgery Partners) GF Value : $28.98 (As of May. 07, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-07), Surgery Partners's share price is $27.77. Surgery Partners's GF Value is $28.98. Therefore, Surgery Partners's Price-to-GF-Value for today is 0.96.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Surgery Partners is Fairly Valued.

Surgery Partners (NAS:SGRY) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Surgery Partners's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	27.77	/	28.98
	=	0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgery Partners GF Value Related Terms

Thank you for viewing the detailed overview of Surgery Partners's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgery Partners (Surgery Partners) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027

Website

https://www.surgerypartners.com

Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.

Executives

Bain Capital Investors Llc	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt	director, officer: Chief Executive Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
T. Devin O'reilly	director, 10 percent owner	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix	director, 10 percent owner
Andrew T. Kaplan	director	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Jason Eric Evans	officer: EVP & Chief Operating Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane	officer: American Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty	officer: Chief Financial Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bradley R. Owens	officer: National Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter	officer: Chief Human Resources Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo	officer: President, Atlantic Group	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock	officer: Sr. VP, Gen Couns. & Sec.	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham	officer: Chief Strategy Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Fund Xi, L.p.	director, 10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Xi, L.p.	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116